Previous reports, including one from our cohort, showed an excess of lipoma in patients with hereditary retinoblastoma compared to nonhereditary survivors [7,8,9], suggesting that germline RB1 mutations may also contribute to benign tumor development. The gene discussed is RB1; the disease is lipoma.